| Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting X Fu, Y Shi, T Qi, S Qiu, Y Huang, X Zhao, Q Sun, G Lin Signal transduction and targeted therapy 5 (1), 262, 2020 | 91 | 2020 |
| Ethosomal gel for improving transdermal delivery of thymosin β-4 X Fu, Y Shi, H Wang, X Zhao, Q Sun, Y Huang, T Qi, G Lin International journal of nanomedicine, 9275-9284, 2019 | 55 | 2019 |
| Development of effective tumor vaccine strategies based on immune response cascade reactions H Wu, X Fu, Y Zhai, S Gao, X Yang, G Zhai Advanced Healthcare Materials 10 (13), 2100299, 2021 | 26 | 2021 |
| Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma Y Huang, Y Shi, Q Wang, T Qi, X Fu, Z Gu, Y Zhang, G Zhai, X Zhao, ... Journal of Controlled Release 316, 208-222, 2019 | 20 | 2019 |
| Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment X Fu, Y Shi, H Zang, Q Wang, Y Wang, H Wu, S Qiu, H Shen, F Mo, ... Journal of Controlled Release 347, 1-13, 2022 | 17 | 2022 |
| The role of antibody delivery formation in cancer therapy T Qi, Y Shi, Y Huang, X Fu, S Qiu, Q Sun, G Lin Journal of Drug Targeting 28 (6), 574-584, 2020 | 7 | 2020 |
| Relaxin-Loaded Inhaled Porous microspheres inhibit idiopathic pulmonary fibrosis and improve pulmonary function Post-bleomycin challenges S Qiu, X Fu, Y Shi, H Zang, Y Zhao, Z Qin, G Lin, X Zhao Molecular Pharmaceutics 20 (8), 3947-3959, 2023 | 2 | 2023 |
| Preparation of Injectable Double-Layer Microspheres for the Long-Term Treatment of Osteoarthritis S Qiu, Y Shi, H Zang, Q Wang, X Fu, H Shen, F Mo, Y Zhang, X Chen, ... Available at SSRN 4233584, 0 | 1 | |
| Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application X Fu, Y Shi, Z Gu, H Zang, L Li, Q Wang, Y Wang, X Zhao, H Wu, S Qiu, ... Asian Journal of Pharmaceutical Sciences, 100925, 2024 | | 2024 |
